EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Huangqin decoction inhibits colorectal inflammatory cancer transformation by improving gut microbiome-mediated metabolic dysfunction

Lu Lu, Yuan Li, Hang Su, Sisi Ren, Yujing Liu, Gaoxuan Shao, Weiwei Liu, Guang Ji, Hanchen Xu

Journal of Pharmaceutical Analysis · 2025-05 · 15 (5) · 101138

DOI: 10.1016/j.jpha.2024.101138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2025-05. Verfasst von Lu Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditiona…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Rising-Star Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Colorectal cancerGut microbiomeHuangqin decoctionInflammatory cancer transformationLipidomics

Autor:innen und Institutionen

  • Institute of Digestive Diseases, Longhua Hospital, China-Canada Center of Research for Digestive Diseases (ccCRDD), Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
  • State Key Laboratory of Integration and Innovation of Classic Formula and Modern Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
  • Shanghai Frontier Research Center of Disease and Syndrome Biology of Inflammatory Cancer Transformation, Shanghai, 200032, China.
  • Department of Laboratory Medicine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Rising-Star Program

Zitieren

APA

Lu, L., Li, Y., Su, H., Ren, S., Liu, Y., Shao, G., Liu, W., Ji, G., & Xu, H. (2025). Huangqin decoction inhibits colorectal inflammatory cancer transformation by improving gut microbiome-mediated metabolic dysfunction. Journal of Pharmaceutical Analysis, 15(5), 101138. https://doi.org/10.1016/j.jpha.2024.101138

Vancouver

Lu L, Li Y, Su H, Ren S, Liu Y, Shao G, et al. Huangqin decoction inhibits colorectal inflammatory cancer transformation by improving gut microbiome-mediated metabolic dysfunction. Journal of Pharmaceutical Analysis. 2025;15(5):101138. doi:10.1016/j.jpha.2024.101138

BibTeX
@article{Lu2025,
  author = {Lu, Lu and Li, Yuan and Su, Hang and Ren, Sisi and Liu, Yujing and Shao, Gaoxuan and Liu, Weiwei and Ji, Guang and Xu, Hanchen},
  title = {Huangqin decoction inhibits colorectal inflammatory cancer transformation by improving gut microbiome-mediated metabolic dysfunction},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2025},
  volume = {15},
  number = {5},
  pages = {101138},
  doi = {10.1016/j.jpha.2024.101138}
}
Kostenlos starten →